<HashMap><database>biostudies-literature</database><scores/><additional><submitter>van der Beek JN</submitter><funding>Stichting Kinderen Kankervrij</funding><pagination>543-552</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9291546</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>55(2)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>The SIOP-Renal Tumor Study Group (RTSG) does not advocate invasive procedures to determine histology before the start of therapy. This may induce misdiagnosis-based treatment initiation, but only for a relatively small percentage of approximately 10% of non-Wilms tumors (non-WTs). MRI could be useful for reducing misdiagnosis, but there is no global consensus on differentiating characteristics.&lt;h4>Purpose&lt;/h4>To identify MRI characteristics that may be used for discrimination of newly diagnosed pediatric renal tumors.&lt;h4>Study type&lt;/h4>Consensus process using a Delphi method.&lt;h4>Population&lt;/h4>Not applicable.&lt;h4>Field strength/sequence&lt;/h4>Abdominal MRI including T1- and T2-weighted imaging, contrast-enhanced MRI, and diffusion-weighted imaging at 1.5 or 3 T.&lt;h4>Assessme</pubmed_abstract><journal>Journal of magnetic resonance imaging : JMRI</journal><pubmed_title>MRI Characteristics of Pediatric Renal Tumors: A SIOP-RTSG Radiology Panel Delphi Study.</pubmed_title><pmcid>PMC9291546</pmcid><funding_grant_id>341</funding_grant_id><pubmed_authors>Di Paolo PL</pubmed_authors><pubmed_authors>Lakatos K</pubmed_authors><pubmed_authors>Graf N</pubmed_authors><pubmed_authors>Mentzel HJ</pubmed_authors><pubmed_authors>Calareso G</pubmed_authors><pubmed_authors>Granata C</pubmed_authors><pubmed_authors>Gavra MM</pubmed_authors><pubmed_authors>Olsen OE</pubmed_authors><pubmed_authors>Vult von Steyern K</pubmed_authors><pubmed_authors>Morosi C</pubmed_authors><pubmed_authors>Varga E</pubmed_authors><pubmed_authors>Nievelstein RAJ</pubmed_authors><pubmed_authors>Schenk JP</pubmed_authors><pubmed_authors>van den Heuvel-Eibrink MM</pubmed_authors><pubmed_authors>Kyncl M</pubmed_authors><pubmed_authors>Breysem L</pubmed_authors><pubmed_authors>Schafer JF</pubmed_authors><pubmed_authors>Coma A</pubmed_authors><pubmed_authors>Lederman HM</pubmed_authors><pubmed_authors>Brisse HJ</pubmed_authors><pubmed_authors>Ducou Le Pointe H</pubmed_authors><pubmed_authors>Hotker AM</pubmed_authors><pubmed_authors>Aertsen M</pubmed_authors><pubmed_authors>Lequin MH</pubmed_authors><pubmed_authors>Littooij AS</pubmed_authors><pubmed_authors>Watson TA</pubmed_authors><pubmed_authors>Swinson S</pubmed_authors><pubmed_authors>de Krijger RR</pubmed_authors><pubmed_authors>van der Beek JN</pubmed_authors></additional><is_claimable>false</is_claimable><name>MRI Characteristics of Pediatric Renal Tumors: A SIOP-RTSG Radiology Panel Delphi Study.</name><description>&lt;h4>Background&lt;/h4>The SIOP-Renal Tumor Study Group (RTSG) does not advocate invasive procedures to determine histology before the start of therapy. This may induce misdiagnosis-based treatment initiation, but only for a relatively small percentage of approximately 10% of non-Wilms tumors (non-WTs). MRI could be useful for reducing misdiagnosis, but there is no global consensus on differentiating characteristics.&lt;h4>Purpose&lt;/h4>To identify MRI characteristics that may be used for discrimination of newly diagnosed pediatric renal tumors.&lt;h4>Study type&lt;/h4>Consensus process using a Delphi method.&lt;h4>Population&lt;/h4>Not applicable.&lt;h4>Field strength/sequence&lt;/h4>Abdominal MRI including T1- and T2-weighted imaging, contrast-enhanced MRI, and diffusion-weighted imaging at 1.5 or 3 T.&lt;h4>Assessme</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Feb</publication><modification>2025-04-25T21:43:03.352Z</modification><creation>2025-02-19T03:53:04.956Z</creation></dates><accession>S-EPMC9291546</accession><cross_references><pubmed>34363274</pubmed><doi>10.1002/jmri.27878</doi></cross_references></HashMap>